Hepalink Pharma IPO Initiation: Take a Chance on Me
Shenzhen Hepalink Pharma Co., Ltd. (002399 CH)Ā is a leading China-based pharmaceutical company with global businesses in pharmaceutical, innovative...
801 Views
Shenzhen Hepalink (ęµ·ēę®) A+H: A Heparin-API King but Nothing Too Exciting
Shenzhen Hepalink is seeking an up to USD 500 million in an A+H listing.The companyĀ is a dominant heparin supplier on a global scale but it is not...
581 Views
ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Happy...
615 Views
Key Drivers of Asia's Healthcare Sector
From a demand perspective, Asiaās population is growing as is longevity. On the supply side, Asiaās number of doctors, nurses, hospitals and...
3.5k Views
Falling Fertility Adds to China's Population Woes
By allowing couples to have up to two children China hopes to reverse its likely population decline. But falling fertility and the pressures of...
4.2k Views